AMP
Lung Cancer Biomarker Testing Survey Reveals Access Gaps, Attitudes in Community, Academic Practices
Premium
The survey conducted by ACCC revealed oncologists' lack of familiarity with biomarker testing guidelines and "prescriptive" attitudes about sharing testing decisions with patients.
AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic
Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.
Increased incidental detection of clonal hematopoiesis and new considerations for mutations in myelodysplastic precursors herald improved precision medicine strategies.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions
Premium
In a survey conducted by an association working group, 40 percent of respondents said they are already offering TMB, with most others planning to do the same within the year.